SCHEMBL6324240

SCHEMBL6324240

Cc1ccc2cccc(C(=O)Cl)c2c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 2/20 0.53
CYP1A2 P05177 2/20 0.53
CNR2 P34972 3/20 0.47
NPC1 O15118 3/20 0.44
RAB9A P51151 3/20 0.44
MTNR1A P48039 1/20 0.42
KMT2A Q03164 3/20 0.41
POLB P06746 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
NR4A1 P22736 1/20 0.40
NR4A2 P43354 1/20 0.40
NR4A3 Q92570 1/20 0.40
KDM4E B2RXH2 2/20 0.40
ALDH1A1 P00352 2/20 0.40
GAA P10253 2/20 0.40
PLA2G2D Q9UNK4 1/20 0.40
PLK1 P53350 1/20 0.40
PLG P00747 1/20 0.39
KLK1 P06870 1/20 0.39
HSD17B10 Q99714 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9228177 0.86 CYP1A2 (0.53) CYP2A6CYP1A2NPC1RAB9AKMT2A
SCHEMBL3391575 0.84 NR4A1 (0.60) CYP2A6CYP1A2CNR2NPC1RAB9A
SCHEMBL6303548 0.84 CYP2A6 (0.55) CYP2A6CYP1A2CNR2NPC1RAB9A
SCHEMBL6915655 0.82 NR4A1 (0.58) CYP2A6CYP1A2CNR2NPC1RAB9A
SCHEMBL6916304 0.82 NR4A1 (0.58) CYP2A6CYP1A2CNR2NPC1RAB9A
SCHEMBL6915657 0.82 NR4A1 (0.58) CYP2A6CYP1A2CNR2NPC1RAB9A
SCHEMBL6914678 0.82 NR4A1 (0.58) CYP2A6CYP1A2CNR2NPC1RAB9A
SCHEMBL6914168 0.82 NR4A1 (0.58) CYP2A6CYP1A2CNR2NPC1RAB9A
SCHEMBL6916300 0.82 NR4A1 (0.58) CYP2A6CYP1A2CNR2NPC1RAB9A
SCHEMBL6914675 0.82 NR4A1 (0.58) CYP2A6CYP1A2CNR2NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050009903-A1 CB2-selective cannabinoid analogues CLEMSON UNIVERSITY 2005-01-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050009903-A1 CB2-selective cannabinoid analogues CNR2, CNR1, GPR68 CYP2A6 774/4885CYP1A2 825/4885CNR2 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.